Seminars in Nuclear Medicine
Volume 37, Issue 4 , Pages 303-313 , July 2007

Pediatric Dual-Energy X-ray Absorptiometry: Technique, Interpretation, and Clinical Applications

  • Larry A. Binkovitz, MD

      Affiliations

    • Department of Radiology, Columbus Children’s Hospital, Columbus, OH.
    • Corresponding Author InformationAddress reprint requests to Larry A. Binkovitz, MD, Department of Radiology, Columbus Children’s Hospital, 700 Children’s Way, Columbus OH 43205.
    • ,
  • Maria J. Henwood, DO

      Affiliations

    • Department of Endocrinology, Columbus Children’s Hospital, Columbus, OH.
    • ,
  • Paul Sparke

      Affiliations

    • Capital University, Columbus, OH.

References 

  1. Lentle BC, Prior JC. Osteoporosis: What a clinician expects to learn from a patient’s bone density examination. Radiology. 2003;228:620–628
  2. Bonnick SL, Johnston CC, Kleerekoper M, et al. Importance of precision in bone density measurements. J Clin Densitom. 2001;4:105–110
  3. The Writing Group for the ISCD. Position Development Conference; Diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom. 2004;7:17–26
  4. Bachrach LK. Dual energy x-ray absorptiometry (DEXA) measurements of bone density and body composition: Promise and pitfalls. J Pediatr Endocrinol Metab. 2000;13:983–988
  5. Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res. 1992;7:137–145
  6. Hammami M, Koo WW, Hockman EM. Technical considerations for fan-beam dual-energy x-ray absorptiometry body composition measurements in pediatric studies. J Parenter Enteral Nutr. 2004;28:328–333
  7. Leonard MB, Feldman HI, Zemel BS, et al. Evaluation of low density spine software for the assessment of bone mineral density in children. J Bone Miner Res. 1998;13:1687–1690
  8. Cheng S, Nicholson PH, Kroger H, et al. Differences in estimates of change of bone accrual and body composition in children because of scan mode selection with the prodigy densitometer. J Clin Densitom. 2005;8:65–73
  9. Simpson DE, Dontu VS, Stephens SE, et al. Large variations occur in bone density measurements of children when using different software. Nucl Med Commun. 2005;26:483–487
  10. Cromer BA, Binkovitz L, Ziegler J, et al. Reference values for bone mineral density in 12- to 18-year-old girls categorized by weight, race, and age. Pediatr Radiol. 2004;34:787–792
  11. Henderson RC. The correlation between dual-energy x-ray absorptiometry measures of bone density in the proximal femur and lumbar spine of children. Skeletal Radiol. 1997;26:544–547
  12. Harcke HT, Taylor A, Bachrach S, et al. Lateral femoral scan: an alternative method for assessing bone mineral density in children with cerebral palsy. Pediatr Radiol. 1998;28:241–246
  13. Henderson RC, Lark RK, Newman JE, et al. Pediatric reference data for dual x-ray absorptiometric measures of normal bone density in the distal femur. AJR Am J Roentgenol. 2002;178:439–443
  14. Ellis KJ, Shypailo RJ, Hardin DS, et al. Z score prediction model for assessment of bone mineral content in pediatric diseases. J Bone Miner Res. 2001;16:1658–1664
  15. Makitie O, Doria AS, Henriques F, et al. Radiographic vertebral morphology: A diagnostic tool in pediatric osteoporosis. J Pediatr. 2005;146:395–401
  16. National Osteoporosis Society. A Practical Guide to Bone Densitometry in Children. Bath, UK: National Osteoporosis Society; 2004;
  17. Wahner HW, Fogelman I. The Evaluation of Osteoporosis: Dual Energy X-Ray Absorptiometry in Clinical Practice. Cambridge: Martin Dunnitz; 1994;
  18. Ho CP, Kim RW, Schaffler MB, et al. Accuracy of dual-energy radiographic absorptiometry of the lumbar spine: Cadaver study. Radiology. 1990;176:171–173
  19. Margulies L, Horlick M, Thornton JC, et al. Reproducibility of pediatric whole body bone and body composition measures by dual-energy x-ray absorptiometry using the GE lunar prodigy. J Clin Densitom. 2005;8:298–304
  20. Glastre C, Braillon P, David L, et al. Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: Correlations with growth parameters. J Clin Endocrinol Metab. 1990;70:1330–1333
  21. McCormick DP, Ponder SW, Fawcett HD, et al. Spinal bone mineral density in 335 normal and obese children and adolescents: Evidence for ethnic and sex differences. J Bone Miner Res. 1991;6:507–513
  22. Bonjour JP, Theintz G, Buchs B, et al. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab. 1991;73:555–563
  23. Faulkner RA, Bailey DA, Drinkwater DT, et al. Regional and total body bone mineral content, bone mineral density, and total body tissue composition in children 8-16 years of age. Calcif Tissue Int. 1993;53:7–12
  24. Sabatier JP, Guaydier-Souquieres G, Benmalek A, et al. Evolution of lumbar bone mineral content during adolescence and adulthood: A longitudinal study in 395 healthy females 10-24 years of age and 206 premenopausal women. Osteoporos Int. 1999;9:476–482
  25. Osteoporosis Prevention, Diagnosis, and Therapy. Available at: http://consensus.nih.gov/2000/2000Osteoporosis111html.htm. Accessed March 14, 2007
  26. American College of Rheumatology. Practice guidelines. Available at: http://www.rheumatology.org/publications/guidelines/index.asp?aud=mem. Accessed March 14, 2007
  27. http://www.acr.org/sacr/bin.asp?TrackID=&SID=1&DID=11796&CID=1206&VID=2 &DOC=File.PDF
  28. Salle BL, Braillon P, Glorieux FH, et al. Lumbar bone mineral content measured by dual energy x-ray absorptiometry in newborns and infants. Acta Paediatr. 1992;81:953–958
  29. Koo WWK, Walters J, Bush AJ, et al. Dual-energy x-ray absorptiometry studies of bone mineral status in newborn infants. J Bone Miner Res. 1996;11:997–1002
  30. Southard RN, Morris JD, Mahan JD. Bone mass in healthy children: Measurement with quantitative DX. Radiology. 1991;179:735–738
  31. Hogler W, Briody J, Woodhead HJ, et al. Importance of lean mass in the interpretation of total body densitometry in children and adolescents. J Pediatr. 2003;143:81–88
  32. Leonard MB, Propert KJ, Zemel BS, et al. Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. J Pediatr. 1999;135:182–188
  33. van Coeverden SCCM, de Ridder CM, Roos JC, et al. Pubertal maturation characteristics and the rate of bone mass development longitudinally toward menarche. J Bone Miner Res. 2001;16:774–778
  34. Crabtree NJ, Kibirige MS, Fordham JN, et al. The relationship between lean body mass and bone mineral content in paediatric health and disease. Bone. 2004;35:965–972
  35. Ponder SW, McCormick DP, Fawcett HD, et al. Spinal bone mineral density in children aged 5.00 through 11.99 years. Am J Dis Child. 1990;144:1346–1348
  36. Boot AM, Bouquet J, de Ridder MAJ, et al. Determinants of body composition measured by dual-energy x-ray absorptiometry in Dutch children and adolescents. Am J Clin Nutr. 1997;66:232–238
  37. van der Sluis IM, de Ridder MAJ, Boot AM, et al. Reference data for bone density and body composition measured with dual energy x-ray absorptiometry in white children and young adults. Arch Dis Child. 2002;87:341–347
  38. Faulkner RA, Bailey DA, Drinkwater DT, et al. The densitometry in Canadian children 8-17 years of age. Calcif Tissue Int. 1996;59:344–351
  39. Molgaard C, Thomsen BL, Michaelsen KF. Influence of weight, age and puberty on bone size and bone mineral content in healthy children and adolescents. Acta Paediatr. 1998;87:494–499
  40. Rico H, Revilla LF, Villa ER, et al. Body composition in children and Tanner’s stages: A study with dual-energy x-ray absorptiometry. Metabolism. 1993;42:967–970
  41. Leonard MB, Propert KJ, Zemel BS, et al. Discrepancies in pediatric bone mineral density reference data: Potential for misdiagnosis of osteopenia. J Pediatr. 1999;135:182–188
  42. Whyte MP, Wenkert D, Clements KL, et al. Bisphosphonate-induced osteopetrosis. N Engl J Med. 2003;349:457–463
  43. Gafni RI, Baron J. Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy x-ray absorptiometry (DEXA). J Pediatr. 2004;144:253–257
  44. Molgaard C, Thomsen BL, Prentice A, et al. Whole body bone mineral content in healthy children and adolescents. Arch Dis Child. 1997;76:9–15
  45. Molgaard C, Michaelsen KF. Evaluation of whole body DXA scans in children. Bone. 2005;36:S73–S74
  46. Binkovitz LA, Henwood MJ. Pediatric DXA technique and interpretation. Pediatr Radiol. 2007;37:21–31
  47. Katzman DK, Bachrach LK, Carter DR, et al. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab. 1991;73:1332–1339
  48. Kroger H, Kotaniemi A, Vainio P. Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry. Bone Miner. 1992;17:75–85
  49. Lu PW, Cowell CT, Lloyd-Jones SA, et al. Volumetric bone mineral density in normal subjects, aged 5-27 years. J Clin Endocrinol Metab. 1996;81:1586–1590
  50. Wren TAL, Liu X, Pitukcheewanont P, et al. Bone acquisition in healthy children and adolescents: comparisons of dual-energy x-ray absorptiometry and computed tomography measures. J Clin Endocrinol Metab. 2005;90:1925–1928
  51. Henderson RC, Hayes PRL. Bone mineralization in children and adolescents with a milk allergy. Bone Miner. 1994;27:1–12
  52. Infante D, Tormo R. risk of inadequate bone mineralizaton in diseases involving long-term suppression of dairy products. J Pediatr Gastroenterol Nutr. 2000;30:310–313
  53. Rockwell JEP, Williams SM, Taylor RW, et al. Two-year changes in bone and body composition in young children with a history of prolonged milk avoidance. Osteoporos Int. 2005;15:1016–1023
  54. Kalayci AG, Kkansu A, Girgin N, et al. Bone mineral density and importance of a gluten-free diet in patients with celiac disease in childhood. Pediatrics. 2001;108:e89
  55. Barera G, Beccio S, Proverbio MC, et al. Longitudinal changes in bone metabolism and bone mineral content in children with celiac disease during consumption of a gluten-free diet. Am J Clin Nutr. 2004;79:148–154
  56. Tau C, Mautalen C, De Rosa S, et al. Bone mineral density in children with celiac disease (Effect of a Gluten-free diet). Eur J Clin Nutr. 2006;60:358–363
  57. Szathmari M, Tulassay T, Arato A, et al. Bone mineral content and density in asymptomatic children with celiac disease on a gluten-free diet. Eur J Gastroenterol Hepatol. 2001;13:419–424
  58. Boot AM, Bouquet J, Krenning EP, et al. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut. 1998;42:188–194
  59. Ahmed SF, Horrocks IA, Patterson T, et al. Bone mineral assessment by dual energy x-ray absorptiometry in children with inflammatory bowel disease: Evaluation by age or bone area. J Pediatr Gastroenterol Nutr. 2004;38:276–281
  60. Burnham JM, Shults J, Semeao E, et al. Whole body BMC in pediatric Crohn disease: Iindependent effects of altered growth, maturation, and body composition. J Bone Miner Res. 2004;19:1961–1968
  61. Walther F, Fusch C, Radke M, et al. Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment. J Pediatr Gastroenterol Nutr. 2006;43:42–51
  62. Argao EA, Specker BL, Heubi JE. Bone mineral content in infants and children with chronic cholestatic liver disease. Pediatrics. 1993;91:1151–1154
  63. Olsen IE, Ittenbach RF, Rovner AJ, et al. Deficits in size-adjusted bone mass in children with Alagille Syndrome. J Pediatr Gastroenterol Nutr. 2005;40:76–82
  64. D’Antiga L, Ballan D, Luisetto G, et al. Long-term outcome of bone mineral density in children who underwent a successful liver transplantation. Transplantation. 2004;78:899–903
  65. Ahmed SF, Russell S, Rashid R, et al. Bone mineral content, corrected for height or bone area, measured by DXA is not reduced in children with chronic renal disease or in hypoparathyroidism. Pediatr Nephrol. 2005;20:1466–1472
  66. Acott PD, Crocker JFS, Wong JA. Decreased bone mineral density in the pediatric renal transplant population. Pediatr Transplant. 2003;7:358–363
  67. Boot AM, Nauta J, de Jong MC, et al. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment. Clin Endocrinol. 1998;49:665–672
  68. van der Sluis IM, Boot AM, Nauta J, et al. Bone density and body composition in chronic renal failure: Effects of growth hormone treatment. Pediatr Nephrol. 2000;15:221–228
  69. Feber J, Cochat P, Braillon P, et al. Bone mineral density after renal transplantation in children. J Pediatr. 1994;125:870–875
  70. Klaus G, Paschen C, Wuster C, et al. Weight-/height-related bone mineral density is not reduced after renal transplantation. Pediatr Nephrol. 1998;12:343–348
  71. Saggese G, Baroncelli GI, Bertelloni S, et al. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency (Role of GH in the attainment of peak bone mass). J Clin Endocrinol Metab. 1996;81:3077–3083
  72. Hogler W, Briody J, Moore B, et al. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Bone. 2005;37:642–650
  73. Lanes R, Gunczler P, Esaa S, et al. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: A 3-year study. Clin Endocrinol. 2002;57:725–730
  74. Baroncelli GI, Bertelloni S, Sodini F, et al. Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD. Clin Endocrinol. 2004;60:175–184
  75. Baroncelli GI, Saggese G. Effect of GH treatment on bone mass in children with GH deficiency. J Endocrinol Invest. 2005;28(10 suppl):23–27
  76. Shoepe HA, Snow CM. Oral contraceptive use in young women is associated with lower bone mineral density than that of controls. Osteoporos Int. 2005;16:1538–1544
  77. Cromer BA, Stager M, Bonny A, et al. Depot medroxyprogestrone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health. 2004;35:434–441
  78. Cromer BA, Blair JM, Mahan JD, et al. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr. 1996;129:671–676
  79. Banks E, Berrington A, Casabonne D. Overview of the relationship between use of progestogen-only contraceptives and bone mineral density. BJOG. 2001;108:1214–1221
  80. Cromer BA, Lazebnik R, Rome E, et al. Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. Am J Obstet Gynecol. 2005;192:42–47
  81. Resch H, Newrkla S, Grampp S, et al. Ultrasound and x-ray-based bone densitometry in patients with anorexia nervosa. Calcif Tissue Int. 2000;66:338–341
  82. Soyka LA, Misra M, Frenchman A, et al. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 2002;87:4177–4185
  83. Milos G, Spindler A, Ruegsegger P, et al. Cortical and trabecular bone density and structure in anorexia nervosa. Osteoporos Int. 2005;16:783–790
  84. Seeman E, Szmukler GI, Formica C, et al. Osteoporosis in anorexia nervosa: The influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res. 1992;7:1467–1474
  85. Sood M, Hambleton G, Super M, et al. Bone status in cystic fibrosis. Arch Dis Child. 2001;84:516–520
  86. Haslam RHM, Borovnicar DJ, Stroud DB, et al. Correlates of prepubertal bone mineral density in cystic fibrosis. Arch Dis Child. 2001;85:166–171
  87. Hardin DS, Arumugam R, Seilheimer DK, et al. Normal bone mineral density in cystic fibrosis. Arch Dis Child. 2001;84:363–368
  88. Buntain HM, Greer RM, Schluter PJ, et al. Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax. 2004;59:149–155
  89. Haworth CS, Selby PL, Webb AK, et al. Low bone mineral density in adults with cystic fibrosis. Thorax. 1999;54:961–967
  90. Henderson RC, Madsen CD. Bone density in children and adolescents with cystic fibrosis. J Pediatr. 1996;128:28–39
  91. Haworth CS, Selby PL, Horrocks AW, et al. A prospective study of change in bone mineral density over one year in adults with cystic fibrosis. Thorax. 2002;57:719–723
  92. Bhudhikanok GS, Wang MC, Marcus R, et al. Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J Pediatr. 1998;133:18–27
  93. Aris RM, Lester GE, Renner JB, et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med. 2000;162:941–946
  94. Aris RM, Lester GE, Caminiti M, et al. Efficacy of alendronate in adults with cystic fibrosis with low bone density. Am J Respir Crit Care Med. 2004;169:77–82
  95. Haworth CS, Selby PL, Adams JE, et al. Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis. Thorax. 2001;56:314–316
  96. Boot AM, de Jongste JC, Verberne AAP, et al. Bone mineral density and bone metabolism of prepubertal children with asthma after long-term treatment with inhaled corticosteroids. Pediatr Pulmonol. 1997;24:379–384
  97. Agertoft L, Pedersen S. Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide. Am J Respir Crit Care Med. 1998;157:178–183
  98. Bahceciler NN, Sezgin G, Nursoy MA, et al. Inhaled corticosteroids and bone density of children with asthma. J Asthma. 2002;39:151–157
  99. Altzntas DU, Karakoc GB, Can S, et al. The effects of long term use of inhaled corticosteroids on linear growth, adrenal function and bone mineral density in children. Allergol Immunopathol. 2005;33:204–209
  100. Allen HDW, Thong IG, Clifton-Bligh P, et al. Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma. Pediatr Pulmonol. 2000;29:188–193
  101. Harris M, Hauser S, Nguyen TV, et al. Bone mineral density in prepubertal asthmatics receiving corticosteroid treatment. J Paediatr Child Health. 2001;37:67–71
  102. Brinker MR, Thomas KA, Meyers SJ, et al. Bone mineral density of the lumbar spine and proximal femur is decreased in children with sickle cell anemia. Am J Orthop. 1998;27:43–49
  103. Soliman AT, Bererhi H, Darwish A, et al. Decreased bone mineral density in prepubertal children with sickle cell disease: Correlation with growth parameters, degree of siderosis and secretion of growth factors. J Trop Pediatr. 1998;44:194–198
  104. Lal A, Fung EB, Pakbaz Z, et al. Bone mineral density in children with sickle cell anemia. Pediatr Blood Cancer. 2006;47:901–906
  105. Buison AM, Kawchak DA, Schall JI, et al. Bone area and bone mineral content deficits in children with sickle cell disease. Pediatrics. 2005;116:943–949
  106. Miller RG, Segal JB, Ashar BH, et al. High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am J Hematol. 2006;81:236–241
  107. Vogiatzi MG, Autio KA, Schneider R, et al. Low bone mass in prepubertal children with thalassemia major: Insights into the pathogenesis of low bone mass in thalassemia. J Pediatr Endocrinol Metab. 2004;17:1415–1421
  108. Benigno V, Bertelloni S, Baroncelli GI, et al. Effects of thalassemia major on bone mineral density in late adolescence. J Pediatr Endocrinol Metab. 2003;16:337–342
  109. Barnes C, Wong P, Egan B, et al. Reduced bone density among children with severe hemophilia. Pediatrics. 2004;114:177–181
  110. Gallacher SJ, Deighan C, Wallace AM, et al. Association of severe haemophilia A with osteoporosis: A densitometric and biochemical study. Q J Med. 1994;87:181–186
  111. Arikoski P, Komulainen J, Voutilainen R, et al. Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 1998;20:234–240
  112. Brennan BMD, Rahim A, Adams JA, et al. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood. Br J Cancer. 1999;79:1859–1863
  113. van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, et al. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 2000;35:415–420
  114. Boot AM, van den Heuvel-Eibrink MM, Hahlen K, et al. Bone mineral density in children with acute lymphoblastic leukaemia. Eur J Cancer. 1999;35:1693–1697
  115. Marinovic D, Dorgeret S, Lescoeur B, et al. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: A 1-year prospective study. Pediatrics. 2005;116:e102–e108
  116. Jarfelt M, Fors H, Lannering B, et al. Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia. Eur J Endoc. 2006;154:303–309
  117. Aisenberg J, Hsieh K, Kalaitzoglou G, et al. J Pediatr Hematol Oncol. 1998;20:241–245
  118. Vassilopoulou-Sellin R, Brosnan P, Delpassand A, et al. Osteopenia in young adult survivors of childhood cancer. Med Pediatr Oncol. 1999;32:272–278
  119. Nysom K, Holm K, Michaelsen KF, et al. Bone mass after treatment of malignant lymphoma in childhood. Med Pediatr Oncol. 2001;37:518–524
  120. Kelly J, Damron T, Grant W, et al. Cross-sectional study of bone mineral density in adult survivors of solid pediatric cancers. J Pediatr Hematol Oncol. 2005;27:248–253
  121. Ruza E, Sierrasesumaga L, Azcona C, et al. Bone mineral density and bone metabolism in children treated for bone sarcomas. Pediatr Res. 2006;59:866–871
  122. Odame I, Duckworth J, Talsma D, et al. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood. Pediatr Blood Cancer. 2006;46:357–362
  123. Henderson RC, Lin PP, Greene WB. Bone-mineral density in children and adolescents who have spastic cerebral palsy. J Bone Joint Surg. 1995;77-A:1671–1681
  124. Henderson RC, Lark RK, Gurka MJ, et al. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics. 2002;110:1–10
  125. Henderson RC, Lark RK, Kecskemethy HH, et al. Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placego-controlled clinical trial. J Pediatr. 2002;141:644–651
  126. Bachrach SJ, Kecskemethy HH, Harcke HT, et al. Pamidronate treatment and posttreatment bone density in children with spastic quadriplegic cerebral palsy. J Clin Densitom. 2006;9:167–174
  127. Quan A, Adams R, Ekmark E, et al. Bone mineral density in children with myelomeningocele. Pediatrics. 1998;102:E34
  128. Valtonen KM, Goksor LA, Jonsson O, et al. Osteoporosis in adults with meningomyelocele: An unrecognized problem at rehabilitation clinics. Arch Phys Med Rehabil. 2006;87:376–382
  129. Pepmueller PH, Cassidy JT, Allen SH, et al. Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1996;39:746–757
  130. Pereira RMR, Corrente JE, Chahade WH, et al. Evaluation by dual x-ray absorptiometry (DXA) of bone mineral density in children with juvenile chronic arthritis. Clin Exp Rheum. 1998;16:495–501
  131. Lien G, Flato B, Haugen M, et al. Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis. Arthritis Rheum. 2003;48:2214–2223
  132. Henderson CJ, Cawkwell GD, Specker BL, et al. Predictors of total body bone mineral density in non-corticosteroid-treated prepubertal children with juvenile rheumatoid arthritis. Arthritis Rheum. 1997;40:1967–1975
  133. Henderson CJ, Specker BL, Sierra RI, et al. Total-body bone mineral content in non-corticosteroid-treated postpubertal females with juvenile rheumatoid arthritis. Arthritis Rheum. 2000;43:531–540
  134. Mul D, van Suijlekom-Smit LWA, ten Cate R, et al. Bone mineral density and body composition and influencing factors in children with rheumatic diseases treated with corticosteroids. J Pediatr Endoc Metab. 2002;15:187–192
  135. Bianchi ML, Cimaz R, Galbiati E, et al. Bone mass change during methotrexate treatment in patients with juvenile rheumatoid arthritis. Osteoporos Int. 1999;10:20–25
  136. Trapani S, Civinini R, Ermini M, et al. Osteoporosis in juvenile systemic lupus erthematosus: a longitudinal study on the effect of steroids on bone mineral density. Rheumatol Int. 1998;18:45–49
  137. Castro TCM, Terreri MT, Szejnfeld VL, et al. Bone mineral density in juvenile systemic lupus erythematosus. Braz J Med Bio Res. 2002;35:1159–1163
  138. Larson CM, Henderson RC. Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop. 2000;20:71
  139. Bianchi ML, Mazzanti A, Galbiati E, et al. Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos Int. 2003;14:761–767
  140. Hawker GA, Ridout R, Harris VA, et al. Alendronate in the treatment of low bone mass in steroid-treated boys with Duchenne’s muscular dystrophy. Arch Phys Med Rehab. 2005;86:284–288
  141. Stewart WA, Acott PD, Salisbury SR, et al. Bone mineral density in juvenile dermatomyositis. Arthritis Rheum. 2003;48:2294–2298
  142. Castro TCM, Terreri MTR, Szejnfeld VL, et al. Bone mineral density of Brazilian girls with juvenile dermatomyositis. Braz J Med Biol Res. 2005;38:309–313
  143. Lund AM, Molgaard C, Muller J, et al. Bone mineral content and collagen defects in osteogenesis imperfecta. Acta Paediatr. 1999;88:1083–1088
  144. Rauch F, Glorieux FH. Bisphosphonate treatment in osteogensis imperfecta: Which drug, for whom, for how long?. Ann Med. 2005;37:295–302
  145. Zacharin M, Kanumakala S. Pamidronate treatment in less severe forms of osteogenesis imperfecta. J Pediatr Endocrinol Metab. 2004;17:1511–1517
  146. Gatti D, Antoniazzi F, Prizzi R, et al. Intravenous neridronate in children with osteogenesis imperfecta: A randomized controlled study. J Bone Miner Res. 2005;20:758–763
  147. Arikoski P, Silverwood B, Tillmann V, et al. Intravenous pamidronate in children with moderate to severe osteogenesis imperfecta: Assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy. Bone. 2004;34:539–546
  148. Letocha AD, Cintas HL, Troendle JF, et al. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement. J Bone Miner Res. 2005;20:977–986
  149. Zeitlin L, Rauch F, Plotkin H, et al. Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. Pediatrics. 2003;111:1030–1036

 Significant portions of this article were adapted from two of the authors’ previous works: Binkovitz LA, Henwood MJ: Pediatric DXA: Technique and interpretation. Pediatr Radiol 37:21-31, 2007; and Binkovitz LA, Sparke P, Henwood MJ: Pediatric DXA: Clinical applications. Pediatr Radiol 2007 Apr 13 [Epub ahead of print]; with kind permission from Springer Science and Business Media.

PII: S0001-2998(07)00028-1

doi: 10.1053/j.semnuclmed.2007.02.007

Seminars in Nuclear Medicine
Volume 37, Issue 4 , Pages 303-313 , July 2007

Article Tools

* Image Usage & Resolution